Found 2309 matching trials
Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients
PHASE1The study is an open-label Phase 1 single dose-escalation safety study of C...
Location
Mayo Clinic Florida
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
The Affiliated People's Hospital of Ningbo University
A Combination Study of CAR-T Therapy in r/r B-NHL
PHASE2In registry studies of CAR-T products that have been marketed globally, pat...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
PHASE1This is a clinical trial to evaluate the feasibility and safety of giving t...
Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
PHASE1This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Location
Shandong Second Provincial General Hospital
CART-meso in Mesothelin Expressing Cancers
PHASE1Phase I study to establish safety and feasibility of intravenously administ...
Location
Abramson Cancer Center of the University of Pennsylvania
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
CD4 CAR+ ZFN-modified T Cells in HIV Therapy
PHASE1This research study is being carried out to study a new way to possibly tre...
Status
Active Not Recruiting
Location
University of Pennsylvania
REACT-01: Reversing Autoimmunity Through Cell Therapy
PHASE1This is a phase 1, open-label, non-randomized study enrolling pediatric and...
Location
Seattle Children's Hospital